It has been reported that luteolin and kaempferol exert therapeutic effects on COPD by inhibiting lung inflammation through reducing the release of inflammatory cytokines such as IL-6, IL-12 and TNF-α [50,51]. This evidence concerns the gene TNF and chronic obstructive pulmonary disease.